Screening has the potential to "medicalize" the screened population by inducing anxiety and causing individuals to change their behavior in an (usually futile) attempt to avoid cancer. Screening ...

Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...

Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCCAmezalpat builds momentum with both ...

Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.

0 = No cancer-related symptoms. Normal lifestyle. 1 = Minor symptoms related to cancer. Capable of nonstrenuous activity. Fully ambulatory. 2 = Ambulatory and capable of all self-care but unable ...

AFP is a leading global news agency providing fast, comprehensive and verified coverage of the events shaping our world and of the issues affecting our daily lives. Drawing from an unparalleled ...

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

With AFP Audio, access a hundred new soundtracks everyday from our national and international news wire and millions of audio archives from up to 15 years ago. Find voices and ambient sounds from ...

Feb. 7, 2025 — Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to ... Personalized Cancer ...

Cancer of the tonsil is a rare type of head and neck cancer. Cancer happens when abnormal cells start to divide and grow in an uncontrolled way. Symptoms often include a painless neck lump and a sore ...

CLINICAL complete response (cCR) is a strong predictor of prognosis in patients with unresectable hepatocellular carcinoma ...